The international expansion before product fit
The board said go global. The product still didn't work for half the US customers. London opened in March. By December, it was a tax.
A series-B founder I worked with opened a London office in March of last year. The board had been pushing for international expansion since the round closed. The home market — the US — was generating revenue but had product fit issues in half its customer base. The London hire was an experienced regional GM with a real network. The narrative was clean: we're going global.
By December, London had produced four customers, two of whom were small. The regional GM had become the founder's most expensive direct report. The product issues in the US had not been fixed because the engineering team had spent the year accommodating internationalization requirements that did not have customers behind them yet. The board update for Q4 used the phrase investment year.
International expansion is the most flattering distraction available to a growth-stage company. It looks like ambition. It produces an office to point at, a logo to add to the website's footer, a hire to mention in the next press cycle. It generates the appearance of forward motion at a moment when the company needs the appearance of forward motion to justify the round. None of these are revenue.
The underlying error is sequencing. Expanding internationally before the home market has a documented, repeatable sales motion means the new geography is not executing the playbook; it is debugging the playbook in a market with different language, different procurement, different regulatory environments, and different customer expectations. The regional GM is solving for both the product fit problem and the localization problem simultaneously, against a board expectation of revenue, with one-tenth the operational support the home market had at the equivalent stage.
The cost is rarely a burn problem in the first year. It is a management bandwidth problem. The founder, the CRO, the head of product all spend disproportionate time on the international initiative because the international initiative is visible and the home market is not. The home market gets less attention precisely when it needs the most. The fit problems that existed in the US in January are still there in December, having been deprioritized in favor of building the SAML SSO that the German prospect needed in October.
The right test for international readiness is not market size. It is playbook portability. Can a regional GM, on day one, execute the same sales motion that closes deals in the home market — same scripts, same ICP, same demo flow, same procurement objections? If the playbook does not yet exist in the home market, there is nothing to port. The expansion is not expansion. It is a second product the company is trying to build before the first one has shipped.
The board pressure to go global is real and often misguided. International revenue looks like a scale signal. It is, more often, a complexity signal. Founders who can push back on the timing — by demonstrating that the home market is the higher-ROI investment for the next six to twelve months — are protecting the company from the most expensive form of momentum theater available.